One study has found that the primary reason patients drop out of GLP-1 medication programs, is due to the side effects caused by the drugs
Studies show that individuals using GLP-1 medications lose significantly more weight than those using lifestyle changes alone
Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons
The direct regulation of GLP-1 on insulin expression is significant for type 2 diabetes (T2D) patients with simple glucose tolerance but normal insulin secretion ( 2 Peptide-based GLP-1 derivatives and small molecule compounds of GLP-1RA There are two main categories of GLP-1 receptor agonists, small molecule compounds and peptide-based GLP-1 derivatives as shown in Figure 1 , including exenatide, liraglutide, dulaglutide, etc
Our findings highlight the potential of simultaneously targeting GLP-1R, Y1-R, and Y2-R and provide evidence suggesting a significant role for Y1-R agonism in the control of food intake and glucoregulation